Diseases, Conditions, Syndromes

Kala-azar treatment failing in Nepal

In a recent study, scientists have concluded that the cure rates of Miltefosine, the only oral drug for visceral leishmaniasis available, have significantly decreased. Miltefosine was introduced in the Indian subcontinent ...

Diseases, Conditions, Syndromes

New approach alters malaria maps

Identifying areas of malarial infection risk depends more on daily temperature variation than on the average monthly temperatures, according to a team of researchers, who believe that their results may also apply to environmentally ...

Medical research

New drug puts malaria under the pump

Researchers have discovered how a new class of antimalarial drugs kills the malaria parasite, showing that the drugs block a pump at the parasite surface, causing it to fill with salt.

Diseases, Conditions, Syndromes

Placental blood flow can influence malaria during pregnancy

Malaria in pregnancy causes a range of adverse effects, including abortions, stillbirths, premature delivery and low infant birth weight. Many of these effects are thought to derive from a placental inflammatory response ...

Diseases, Conditions, Syndromes

Statin drug shows promise for fighting malaria effects

Researchers have discovered that adding lovastatin, a widely used cholesterol-lowering drug, to traditional antimalarial treatment decreases neuroinflammation and protects against cognitive impairment in a mouse model of ...

page 38 from 40